Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

[A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].

Lai YY, Li N, Feng L, Shi Y, Dang H, He Q, Wang Z, Wang XY, Li Y, Liu Q, Huang XJ.

Zhonghua Yi Xue Za Zhi. 2013 Oct 29;93(40):3175-9. Chinese.

PMID:
24405535
2.

[Karyotype analysis and fluorescence in situ hybridization detection of 122 patients with myelodysplastic syndrome].

Jing Y, Lin S, Jiang F, Wang F, Fang M.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2016 Apr;33(2):221-6. doi: 10.3760/cma.j.issn.1003-9406.2016.02.021. Chinese.

PMID:
27060321
3.

Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.

Lai YY, Huang XJ, Li J, Zou P, Xu ZF, Sun H, Shao ZH, Zhou DB, Chen FP, Liu ZG, Zhu HL, Wu DP, Wang C, Zhang Y, Li Y, Hou M, Du X, Wang X, Li W, Lai YR, Zhou J, Zhou YH, Fang MY, Qiu L, Wang XM, Zhang GS, Jiang M, Liang YM, Zhang LS, Chen XQ, Bai H, Lin JY.

Leuk Res. 2015 May;39(5):530-5. doi: 10.1016/j.leukres.2015.02.005. Epub 2015 Feb 18.

PMID:
25823643
4.
5.

[Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].

Shen Y, Xue Y, Li J, Pan J, Wu Y, Chen S.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2003 Apr;20(2):160-3. Chinese.

PMID:
12673589
6.

Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.

Chen L, Li J, Zhu Y, Qiu H, Pan J, Wang R, Qian S, Xu W, Xue Y.

Exp Oncol. 2007 Dec;29(4):299-303.

PMID:
18199987
7.

Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.

Kawankar N, Jijina F, Ghosh K, Vundinti BR.

Cancer Epidemiol. 2011 Aug;35(4):e1-5. doi: 10.1016/j.canep.2010.11.009. Epub 2010 Dec 28.

PMID:
21193364
8.

[Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].

Gao DG, Li BT, Zhou LN, Chen H, Zhang B.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1190-4. doi: 10.7534/j.issn.1009-2137.2013.05.021. Chinese.

PMID:
24156432
9.

Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.

Mallo M, Arenillas L, Espinet B, Salido M, Hernández JM, Lumbreras E, del Rey M, Arranz E, Ramiro S, Font P, González O, Renedo M, Cervera J, Such E, Sanz GF, Luño E, Sanzo C, González M, Calasanz MJ, Mayans J, García-Ballesteros C, Amigo V, Collado R, Oliver I, Carbonell F, Bureo E, Insunza A, Yañez L, Muruzabal MJ, Gómez-Beltrán E, Andreu R, León P, Gómez V, Sanz A, Casasola N, Moreno E, Alegre A, Martín ML, Pedro C, Serrano S, Florensa L, Solé F.

Haematologica. 2008 Jul;93(7):1001-8. doi: 10.3324/haematol.13012.

10.

Prognostic classification of MDS is improved by the inclusion of FISH panel testing with conventional cytogenetics.

Kokate P, Dalvi R, Koppaka N, Mandava S.

Cancer Genet. 2017 Oct;216-217:120-127. doi: 10.1016/j.cancergen.2017.05.004. Epub 2017 Aug 16.

PMID:
29025586
11.

[Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].

Cao P, Li Y, Li X, Zhang G, Chen F.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 Jun;39(6):605-11. doi: 10.11817/j.issn.1672-7347.2014.06.010. Chinese.

12.

Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization.

Wilkens L, Burkhardt D, Tchinda J, Büsche G, Werner M, Nolte M, Ganser A, Georgii A.

Diagn Mol Pathol. 1999 Mar;8(1):47-53.

PMID:
10408793
13.
14.

Interphase FISH does not improve the detection of DEL(5q) and DEL(20q) in myelodysplastic syndromes.

Douet-Guilbert N, Herry A, LE Bris MJ, Guéganic N, Bovo C, Morel F, DE Braekeleer M.

Anticancer Res. 2011 Mar;31(3):1007-10.

PMID:
21498729
15.

[Detection of chromosome abnormalities in myelodysplastic syndromes with interval fluorescence in situ hybridization].

Ru X, Li Q, Fang XS, Li Y, Wang X, Zhang LY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):116-20. doi: 10.7534/j.issn.1009-2137.2013.01.024. Chinese.

PMID:
23484703
16.

[Analysis of complex chromosomal aberrations in patients with myelodysplastic syndromes using multiplex fluorescence in situ hybridization combined with whole chromosome painting].

Chen LJ, Li JY, Xiao B, Zhu Y, Liu Q, Pan JL, Qiu HR, Fan L, Zhang SJ, Lu RN, Xu W, Xue YQ.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Dec;24(6):635-9. Chinese.

PMID:
18067073
17.

The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure.

Jiang H, Xue Y, Wang Q, Pan J, Wu Y, Zhang J, Bai S, Wang Q, He G, Sun A, Wu D, Chen S.

Leuk Res. 2012 Apr;36(4):448-52. doi: 10.1016/j.leukres.2011.10.014. Epub 2011 Nov 1.

PMID:
22047706
18.

Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients.

Romeo M, Chauffaille Mde L, Silva MR, Bahia DM, Kerbauy J.

Leuk Res. 2002 Nov;26(11):993-6.

PMID:
12363467
19.

Multiplex fluorescence in situ hybridization in identifying chromosome involvement of complex karyotypes in de novo myelodysplastic syndromes and acute myeloid leukemia.

Xu W, Li JY, Liu Q, Zhu Y, Pan JL, Qiu HR, Xue YQ.

Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e86-95. doi: 10.1111/j.1751-553X.2008.01101.x. Epub 2008 Oct 13.

PMID:
20089000
20.

Supplemental Content

Support Center